Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Gatekeeper role of brain antigen-presenting CD11c+ cells in neuroinflammation.
[LACTRIMS consensus document for the pharmacological treatment of the multiple sclerosis and its clinical variants].
Correction: Optic Nerve Magnetisation Transfer Ratio after Acute Optic Neuritis Predicts Axonal and Visual Outcomes.
Oral Palmitoylethanolamide Treatment Is Associated with Reduced Cutaneous Adverse Effects of Interferon-β1a and Circulating Proinflammatory Cytokines in Relapsing-Remitting Multiple Sclerosis.
[Diet and multiple sclerosis].
Immunological effects of methylprednisolone pulse treatment in progressive multiple sclerosis.
Multiple sclerosis in New Zealand.
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections.
T Cell Activation Regulates CD6 Alternative Splicing by Transcription Dynamics and SRSF1.
Possible clinical outcome measures for clinical trials in patients with multiple sclerosis.
Myeloid Kruppel-like factor 2 deficiency exacerbates neurological dysfunction and neuroinflammation in a murine model of multiple sclerosis.
Slowed Exercise-Onset Vo2 Kinetics During Submaximal Endurance Exercise in Subjects With Multiple Sclerosis.
Emerging role of interleukin-22 in autoimmune diseases.
Symptomatic Sinus Bradycardia After a Treatment Course Of High-dose Oral Prednisone.
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
The value of cerebral Doppler venous haemodynamics in the assessment of multiple sclerosis.
Small-molecule Klotho enhancers as novel treatment of neurodegeneration.
Comment on: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Longitudinally extensive optic neuritis as an MRI biomarker distinguishes neuromyelitis optica from multiple sclerosis.
Effect of integrated Yoga on neurogenic bladder dysfunction in patients with multiple sclerosis-A prospective observational case series.
[Intrathecal immunoglobulin production in the diagnosis and differential diagnosis of multiple sclerosis.]
Lentivirus-mediated estrogen receptor α overexpression in the central nervous system ameliorates experimental autoimmune encephalomyelitis in mice.
Anoctamin 2 identified as an autoimmune target in multiple sclerosis.
[Research progresses of monoclonal antibodies therapy in neuromyelitis optica].
The effectiveness of fingolimod in a Portuguese real-world population.

Pages